IBT Publications by Zitron


Journal Articles (4)

D. Hassel, E. P. Scholz, N. Trano, O. Friedrich, S. Just, B. Meder, D. L. Weiss, E. Zitron, S. Marquardt, C. A. Karle, G. Seemann, M. C. Fishman, H. A. Katus, and W. Rottbauer.
Deficient zebrafish ether-a-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants.
In Circulation, vol. 117(7) , pp. 866--875, 2008
  PDF    
D. Scherer, D. Hassel, R. Bloehs, E. Zitron, K. von Lowenstern, C. Seyler, D. Thomas, F. Konrad, H. F. Burgers, G. Seemann, W. Rottbauer, H. A. Katus, C. A. Karle, and E. P. Scholz.
Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents.
In British Journal of Pharmacology, vol. 156(2) , pp. 226-236, 2009
  PDF    
  
  
E. P. Scholz, P. Carrillo-Bustamante, F. Fischer, M. Wilhelms, E. Zitron, O. Dössel, H. A. Katus, and G. Seemann.
Rotor termination is critically dependent on kinetic properties of I kur inhibitors in an in silico model of chronic atrial fibrillation.
In PloS one, vol. 8(12) , pp. e83179, 2013
  PDF    
  
  
E. P. Scholz, F. M. Konrad, D. L. Weiss, E. Zitron, C. Kiesecker, R. Bloehs, M. Kulzer, D. Thomas, S. Kathöfer, A. Bauer, M. H. Maurer, G. Seemann, H. A. Katus, and C. A. Karle.
Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: block attenuation by mutations of the pore residues Y652 or F656.
In Naunyn-Schmiedebergís Arch. Pharmacol., vol. 376(4) , pp. 275-284, 2007
  PDF